Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
54.34
-1.30 (-2.34%)
At close: Oct 10, 2025, 4:00 PM EDT
53.70
-0.64 (-1.18%)
After-hours: Oct 10, 2025, 7:58 PM EDT
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of $1.03 billion as of October 10, 2025. Its market cap has increased by 384.06% in one year.
Market Cap
1.03B
Enterprise Value
1.03B
1-Year Change
384.06%
Ranking
Category
Stock Price
$54.34
Market Cap Chart
Since December 1, 1998, Nektar Therapeutics's market cap has increased from $478.60M to $1.03B, an increase of 115.94%. That is a compound annual growth rate of 2.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 1.03B | 502.62% |
Dec 31, 2024 | 171.50M | 59.09% |
Dec 29, 2023 | 107.80M | -74.62% |
Dec 30, 2022 | 424.80M | -82.96% |
Dec 31, 2021 | 2.49B | -18.24% |
Dec 31, 2020 | 3.05B | -19.69% |
Dec 31, 2019 | 3.80B | -33.26% |
Dec 31, 2018 | 5.69B | -39.50% |
Dec 29, 2017 | 9.40B | 401.47% |
Dec 30, 2016 | 1.88B | -16.61% |
Dec 31, 2015 | 2.25B | 12.95% |
Dec 31, 2014 | 1.99B | 51.06% |
Dec 31, 2013 | 1.32B | 54.43% |
Dec 31, 2012 | 853.40M | 33.30% |
Dec 30, 2011 | 640.20M | -47.19% |
Dec 31, 2010 | 1.21B | 39.56% |
Dec 31, 2009 | 868.60M | 68.99% |
Dec 31, 2008 | 514.00M | -16.91% |
Dec 31, 2007 | 618.60M | -54.96% |
Dec 29, 2006 | 1.37B | -4.78% |
Dec 30, 2005 | 1.44B | -15.13% |
Dec 31, 2004 | 1.70B | 122.51% |
Dec 31, 2003 | 763.80M | 70.57% |
Dec 31, 2002 | 447.80M | -56.04% |
Dec 31, 2001 | 1.02B | -55.42% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 748.25B |
Johnson & Johnson | 459.32B |
AbbVie | 407.19B |
UnitedHealth Group | 321.06B |
AstraZeneca | 264.75B |
Novo Nordisk | 260.80B |
Novartis AG | 253.85B |
Abbott Laboratories | 230.73B |